These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8040268)

  • 1. Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor.
    Watson JB; Getzler SB; Mosher DF
    J Clin Invest; 1994 Jul; 94(1):261-8. PubMed ID: 8040268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor.
    Brown KJ; Parish CR
    Biochemistry; 1994 Nov; 33(46):13918-27. PubMed ID: 7524669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells.
    Nugent MA; Karnovsky MJ; Edelman ER
    Circ Res; 1993 Dec; 73(6):1051-60. PubMed ID: 8222077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced overexpression of basic fibroblast growth factor, basic fibroblast growth factor receptor, and cell-associated proteoheparan sulfate in cultured coronary smooth muscle cells.
    Skaletz-Rorowski A; Schmidt A; Breithardt G; Buddecke E
    Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):1063-9. PubMed ID: 8696947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
    Krufka A; Guimond S; Rapraeger AC
    Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response.
    Fannon M; Forsten KE; Nugent MA
    Biochemistry; 2000 Feb; 39(6):1434-45. PubMed ID: 10684625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA.
    Aviezer D; Iozzo RV; Noonan DM; Yayon A
    Mol Cell Biol; 1997 Apr; 17(4):1938-46. PubMed ID: 9121441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
    Brown KJ; Hendry IA; Parish CR
    J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial proteoglycans inhibit bFGF binding and mitogenesis.
    Forsten KE; Courant NA; Nugent MA
    J Cell Physiol; 1997 Aug; 172(2):209-20. PubMed ID: 9258342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions.
    Klagsbrun M
    Semin Cancer Biol; 1992 Apr; 3(2):81-7. PubMed ID: 1378313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of cell surface-associated basic fibroblast growth factor by glycosylphosphatidylinositol-specific phospholipase C.
    Bashkin P; Neufeld G; Gitay-Goren H; Vlodavsky I
    J Cell Physiol; 1992 Apr; 151(1):126-37. PubMed ID: 1313817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of cell surface heparan sulfates decreases the high affinity binding of basic FGF to endothelial cells, but not to FRTL-5 rat thyroid cells.
    Emoto N; Isozaki O; Ohmura E; Shizume K; Tsushima T; Demura H
    Thyroid; 1995 Dec; 5(6):455-60. PubMed ID: 8808095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfate moieties in the subendothelial extracellular matrix are involved in basic fibroblast growth factor sequestration, dimerization, and stimulation of cell proliferation.
    Miao HQ; Ishai-Michaeli R; Atzmon R; Peretz T; Vlodavsky I
    J Biol Chem; 1996 Mar; 271(9):4879-86. PubMed ID: 8617759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
    Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
    J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human recombinant insulin-like growth factor I and -II stimulate the expression of basic fibroblast growth factor but suppress the division of bovine coronary smooth muscle cells.
    Schriever C; Schmidt A; Breithardt G; Buddecke E
    Atherosclerosis; 1996 May; 122(2):255-63. PubMed ID: 8769688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible mechanism for lead inhibition of vascular endothelial cell proliferation: a lower response to basic fibroblast growth factor through inhibition of heparan sulfate synthesis.
    Fujiwara Y; Kaji T
    Toxicology; 1999 Apr; 133(2-3):147-57. PubMed ID: 10378481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDGF (chicken embryo fibroblast-derived growth factor) is mitogenically related to TGF-beta and modulates PDGF, bFGF, and IGF-I action on sparse NIH/3T3 cells.
    Geistlich A; Gehring H
    Exp Cell Res; 1993 Feb; 204(2):329-35. PubMed ID: 8440329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
    Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
    J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor.
    Miao HQ; Fritz TA; Esko JD; Zimmermann J; Yayon A; Vlodavsky I
    J Cell Biochem; 1995 Feb; 57(2):173-84. PubMed ID: 7759555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cells.
    Jayson GC; Gallagher JT
    Br J Cancer; 1997; 75(1):9-16. PubMed ID: 9000592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.